Abstract
The authors regret that the following statement was omitted from the Acknowledgements section of the above published article: The University of Arkansas for Medical Sciences and Drs. G.Z., M.H.-J., P.A.C., and C.M.C. have financial interests in (2R,8′S,3′E)-δ-tocodienol discussed in this report. These financial interests have been reviewed and approved in accordance with the university's conflict of interest policies. The authors would like to apologise for any inconvenience caused.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 5943 |
| Number of pages | 1 |
| Journal | Tetrahedron |
| Volume | 72 |
| Issue number | 39 |
| DOIs |
|
| State | Published - 2016 |
| Externally published | Yes |
ASJC Scopus subject areas
- Biochemistry
- Drug Discovery
- Organic Chemistry
Fingerprint
Dive into the research topics of 'Erratum: Corrigendum to ‘Synthesis of (2R,8′S,3′E)-δ-tocodienol, a tocoflexol family member designed to have a superior pharmacokinetic profile compared to δ-tocotrienol’ (Tetrahedron (2016) 72(27–28) (4001–4006))'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS